Amber Uppal

Doctor of Osteopathic Medicine,  CharitĂ© - Universitätsmedizin Berlin 

Location: Germany

Consulting Services

Grant Submission Biostatistics Journal Manuscript Hospital-Pharmacy-Insurance

Areas Of Interest

Cytochrome P-450 Sterol 26-Hydroxylase Infection, Rickettsia typhi Bacterial Vaccines Cells, iNKT E12 Helix-Loop-Helix Protein Quinuclidin-3'-yl-1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylate monosuccinate Interactions, Double Bind Genotype Calling Methods Cyclings, Futile Substrate Acetfenolisatin Ellis Van Creveld Syndrome Antivaccination Movements Ventilatory Muscles Uroplakins Connectomics Area, Forested Creatine Kinase, Mitochondrial Form Diffuse Undifferentiated Lymphomas Retinoblastoma-Like Protein 2 Clear-Cell Sugar Tumors Influenza Pandemics, 1918-1919 Cycle-Transition Point, Cell Cardiac Ruptures, Post-Infarction Meclizine Dihydrochloride Lactobacillales Primary Neoplasms, Cerebellum Psychotherapy, Cognitive Otolaryngology Amifostine Disodium Salt Oxidase 4, NADPH Cytochalasin B Adrenergic beta-1 Receptor Agonist Psychology, Forensic Space Privacy Activator-Deficient Tay-Sachs Disease

Professional Narrative

Dr. Amber Uppal was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Uppal has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Medical Writer, Mayo Clinic 1997
Director Medicine, Harvard Med 2003

Education

Master of Science in physician assistant, Baylor College 2006
Director Medicine, Weill Medical College 1991

Referees


Publications

Platt RJ, Chen S, Zhou Y, Yim MJ, Swiech L, Kempton HR, Dahlman JE, Parnas O, Eisenhaure TM, Jovanovic M, Graham DB, Jhunjhunwala S, Heidenreich M, Xavier RJ, Langer R, Anderson DG, Hacohen N, Regev A, Feng G, Sharp PA, Zhang F. CRISPR- Cas9 knockin mice for genome editing and cancer modeling. Cell. 2014 Oct 9;159(2):440-55. doi: 10.1016/j.cell.2014.09.014. Epub 2014 Sep 25. PMID: 25263330; PMCID: PMC4265475.

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :